BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

Benzinga · 2d ago
BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.